nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2D6—Alzheimer's disease	0.233	1	CbGaD
Cyclophosphamide—CYP2A6—Memantine—Alzheimer's disease	0.128	0.239	CbGbCtD
Cyclophosphamide—CYP2B6—Memantine—Alzheimer's disease	0.0831	0.156	CbGbCtD
Cyclophosphamide—CYP2D6—Rivastigmine—Alzheimer's disease	0.0579	0.109	CbGbCtD
Cyclophosphamide—CYP2C19—Memantine—Alzheimer's disease	0.0528	0.099	CbGbCtD
Cyclophosphamide—CYP2C9—Donepezil—Alzheimer's disease	0.0506	0.0949	CbGbCtD
Cyclophosphamide—CYP2D6—Donepezil—Alzheimer's disease	0.0463	0.0868	CbGbCtD
Cyclophosphamide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0368	0.0691	CbGbCtD
Cyclophosphamide—CYP2D6—Galantamine—Alzheimer's disease	0.0298	0.0559	CbGbCtD
Cyclophosphamide—CYP3A4—Donepezil—Alzheimer's disease	0.0294	0.0552	CbGbCtD
Cyclophosphamide—CYP3A4—Galantamine—Alzheimer's disease	0.019	0.0356	CbGbCtD
Cyclophosphamide—Ifosfamide—PTGS1—Alzheimer's disease	0.00199	1	CrCbGaD
Cyclophosphamide—Arrhythmia—Galantamine—Alzheimer's disease	0.000414	0.00227	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000412	0.00226	CcSEcCtD
Cyclophosphamide—Weight increased—Donepezil—Alzheimer's disease	0.000408	0.00224	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000405	0.00222	CcSEcCtD
Cyclophosphamide—Pneumonia—Donepezil—Alzheimer's disease	0.000402	0.0022	CcSEcCtD
Cyclophosphamide—Bronchospasm—Memantine—Alzheimer's disease	0.000401	0.00219	CcSEcCtD
Cyclophosphamide—Sweating increased—Memantine—Alzheimer's disease	0.000397	0.00217	CcSEcCtD
Cyclophosphamide—Dysgeusia—Galantamine—Alzheimer's disease	0.000395	0.00216	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000394	0.00216	CcSEcCtD
Cyclophosphamide—Renal failure—Donepezil—Alzheimer's disease	0.000393	0.00215	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Donepezil—Alzheimer's disease	0.000392	0.00215	CcSEcCtD
Cyclophosphamide—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000392	0.00215	CcSEcCtD
Cyclophosphamide—Jaundice—Donepezil—Alzheimer's disease	0.00039	0.00213	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Donepezil—Alzheimer's disease	0.000389	0.00213	CcSEcCtD
Cyclophosphamide—Sweating increased—Rivastigmine—Alzheimer's disease	0.000388	0.00213	CcSEcCtD
Cyclophosphamide—Muscle spasms—Galantamine—Alzheimer's disease	0.000388	0.00212	CcSEcCtD
Cyclophosphamide—Pancytopenia—Memantine—Alzheimer's disease	0.000387	0.00212	CcSEcCtD
Cyclophosphamide—Sweating—Donepezil—Alzheimer's disease	0.000383	0.0021	CcSEcCtD
Cyclophosphamide—Haematuria—Donepezil—Alzheimer's disease	0.000381	0.00209	CcSEcCtD
Cyclophosphamide—Vision blurred—Galantamine—Alzheimer's disease	0.00038	0.00208	CcSEcCtD
Cyclophosphamide—Tremor—Galantamine—Alzheimer's disease	0.000378	0.00207	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000374	0.00205	CcSEcCtD
Cyclophosphamide—Anaemia—Galantamine—Alzheimer's disease	0.000373	0.00204	CcSEcCtD
Cyclophosphamide—Weight increased—Memantine—Alzheimer's disease	0.000371	0.00203	CcSEcCtD
Cyclophosphamide—Agitation—Galantamine—Alzheimer's disease	0.000371	0.00203	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Memantine—Alzheimer's disease	0.000367	0.00201	CcSEcCtD
Cyclophosphamide—Bradycardia—Donepezil—Alzheimer's disease	0.000365	0.002	CcSEcCtD
Cyclophosphamide—Pneumonia—Memantine—Alzheimer's disease	0.000365	0.002	CcSEcCtD
Cyclophosphamide—Malaise—Galantamine—Alzheimer's disease	0.000364	0.00199	CcSEcCtD
Cyclophosphamide—Weight increased—Rivastigmine—Alzheimer's disease	0.000363	0.00199	CcSEcCtD
Cyclophosphamide—Haemoglobin—Donepezil—Alzheimer's disease	0.000361	0.00198	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00036	0.00197	CcSEcCtD
Cyclophosphamide—Rhinitis—Donepezil—Alzheimer's disease	0.00036	0.00197	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000359	0.00197	CcSEcCtD
Cyclophosphamide—Haemorrhage—Donepezil—Alzheimer's disease	0.000359	0.00197	CcSEcCtD
Cyclophosphamide—Hepatitis—Donepezil—Alzheimer's disease	0.000359	0.00197	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000358	0.00196	CcSEcCtD
Cyclophosphamide—Pneumonia—Rivastigmine—Alzheimer's disease	0.000357	0.00196	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000357	0.00196	CcSEcCtD
Cyclophosphamide—Renal failure—Memantine—Alzheimer's disease	0.000357	0.00195	CcSEcCtD
Cyclophosphamide—Palpitations—Galantamine—Alzheimer's disease	0.000356	0.00195	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000356	0.00195	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Memantine—Alzheimer's disease	0.000356	0.00195	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Memantine—Alzheimer's disease	0.000353	0.00193	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000352	0.00193	CcSEcCtD
Cyclophosphamide—Cough—Galantamine—Alzheimer's disease	0.000352	0.00193	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00035	0.00192	CcSEcCtD
Cyclophosphamide—Convulsion—Galantamine—Alzheimer's disease	0.000349	0.00191	CcSEcCtD
Cyclophosphamide—Renal failure—Rivastigmine—Alzheimer's disease	0.000349	0.00191	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000348	0.00191	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000348	0.00191	CcSEcCtD
Cyclophosphamide—Hypertension—Galantamine—Alzheimer's disease	0.000348	0.00191	CcSEcCtD
Cyclophosphamide—Haematuria—Memantine—Alzheimer's disease	0.000346	0.0019	CcSEcCtD
Cyclophosphamide—Visual impairment—Donepezil—Alzheimer's disease	0.000346	0.00189	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000345	0.00189	CcSEcCtD
Cyclophosphamide—Chest pain—Galantamine—Alzheimer's disease	0.000343	0.00188	CcSEcCtD
Cyclophosphamide—Myalgia—Galantamine—Alzheimer's disease	0.000343	0.00188	CcSEcCtD
Cyclophosphamide—Arthralgia—Galantamine—Alzheimer's disease	0.000343	0.00188	CcSEcCtD
Cyclophosphamide—Sweating—Rivastigmine—Alzheimer's disease	0.000341	0.00186	CcSEcCtD
Cyclophosphamide—Discomfort—Galantamine—Alzheimer's disease	0.000339	0.00186	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Memantine—Alzheimer's disease	0.000339	0.00186	CcSEcCtD
Cyclophosphamide—Haematuria—Rivastigmine—Alzheimer's disease	0.000339	0.00185	CcSEcCtD
Cyclophosphamide—Tinnitus—Donepezil—Alzheimer's disease	0.000335	0.00183	CcSEcCtD
Cyclophosphamide—Confusional state—Galantamine—Alzheimer's disease	0.000332	0.00182	CcSEcCtD
Cyclophosphamide—Bradycardia—Memantine—Alzheimer's disease	0.000332	0.00182	CcSEcCtD
Cyclophosphamide—Haemoglobin—Memantine—Alzheimer's disease	0.000328	0.00179	CcSEcCtD
Cyclophosphamide—Rhinitis—Memantine—Alzheimer's disease	0.000327	0.00179	CcSEcCtD
Cyclophosphamide—Hepatitis—Memantine—Alzheimer's disease	0.000326	0.00179	CcSEcCtD
Cyclophosphamide—Haemorrhage—Memantine—Alzheimer's disease	0.000326	0.00179	CcSEcCtD
Cyclophosphamide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000325	0.00178	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Memantine—Alzheimer's disease	0.000324	0.00178	CcSEcCtD
Cyclophosphamide—Shock—Galantamine—Alzheimer's disease	0.000324	0.00177	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000322	0.00176	CcSEcCtD
Cyclophosphamide—Chills—Donepezil—Alzheimer's disease	0.000322	0.00176	CcSEcCtD
Cyclophosphamide—Tachycardia—Galantamine—Alzheimer's disease	0.000321	0.00176	CcSEcCtD
Cyclophosphamide—Arrhythmia—Donepezil—Alzheimer's disease	0.000321	0.00176	CcSEcCtD
Cyclophosphamide—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00032	0.00176	CcSEcCtD
Cyclophosphamide—Rhinitis—Rivastigmine—Alzheimer's disease	0.00032	0.00175	CcSEcCtD
Cyclophosphamide—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000319	0.00175	CcSEcCtD
Cyclophosphamide—Hepatitis—Rivastigmine—Alzheimer's disease	0.000319	0.00175	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000318	0.00174	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000317	0.00174	CcSEcCtD
Cyclophosphamide—Alopecia—Donepezil—Alzheimer's disease	0.000317	0.00174	CcSEcCtD
Cyclophosphamide—Visual impairment—Memantine—Alzheimer's disease	0.000314	0.00172	CcSEcCtD
Cyclophosphamide—Anorexia—Galantamine—Alzheimer's disease	0.000314	0.00172	CcSEcCtD
Cyclophosphamide—Erythema—Donepezil—Alzheimer's disease	0.000313	0.00171	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Memantine—Alzheimer's disease	0.000308	0.00169	CcSEcCtD
Cyclophosphamide—Hypotension—Galantamine—Alzheimer's disease	0.000308	0.00168	CcSEcCtD
Cyclophosphamide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000307	0.00168	CcSEcCtD
Cyclophosphamide—Dysgeusia—Donepezil—Alzheimer's disease	0.000306	0.00168	CcSEcCtD
Cyclophosphamide—Tinnitus—Memantine—Alzheimer's disease	0.000304	0.00166	CcSEcCtD
Cyclophosphamide—Flushing—Memantine—Alzheimer's disease	0.000303	0.00166	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000302	0.00165	CcSEcCtD
Cyclophosphamide—Muscle spasms—Donepezil—Alzheimer's disease	0.0003	0.00165	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0003	0.00164	CcSEcCtD
Cyclophosphamide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000297	0.00163	CcSEcCtD
Cyclophosphamide—Flushing—Rivastigmine—Alzheimer's disease	0.000296	0.00162	CcSEcCtD
Cyclophosphamide—Paraesthesia—Galantamine—Alzheimer's disease	0.000296	0.00162	CcSEcCtD
Cyclophosphamide—Vision blurred—Donepezil—Alzheimer's disease	0.000295	0.00161	CcSEcCtD
Cyclophosphamide—Tremor—Donepezil—Alzheimer's disease	0.000293	0.0016	CcSEcCtD
Cyclophosphamide—Chills—Memantine—Alzheimer's disease	0.000292	0.0016	CcSEcCtD
Cyclophosphamide—Arrhythmia—Memantine—Alzheimer's disease	0.000291	0.00159	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00029	0.00159	CcSEcCtD
Cyclophosphamide—Anaemia—Donepezil—Alzheimer's disease	0.000289	0.00158	CcSEcCtD
Cyclophosphamide—Alopecia—Memantine—Alzheimer's disease	0.000288	0.00158	CcSEcCtD
Cyclophosphamide—Agitation—Donepezil—Alzheimer's disease	0.000287	0.00157	CcSEcCtD
Cyclophosphamide—Chills—Rivastigmine—Alzheimer's disease	0.000286	0.00157	CcSEcCtD
Cyclophosphamide—Decreased appetite—Galantamine—Alzheimer's disease	0.000286	0.00157	CcSEcCtD
Cyclophosphamide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000285	0.00156	CcSEcCtD
Cyclophosphamide—Fatigue—Galantamine—Alzheimer's disease	0.000284	0.00155	CcSEcCtD
Cyclophosphamide—Malaise—Donepezil—Alzheimer's disease	0.000282	0.00154	CcSEcCtD
Cyclophosphamide—Alopecia—Rivastigmine—Alzheimer's disease	0.000282	0.00154	CcSEcCtD
Cyclophosphamide—Constipation—Galantamine—Alzheimer's disease	0.000281	0.00154	CcSEcCtD
Cyclophosphamide—Dysgeusia—Memantine—Alzheimer's disease	0.000278	0.00152	CcSEcCtD
Cyclophosphamide—Erythema—Rivastigmine—Alzheimer's disease	0.000278	0.00152	CcSEcCtD
Cyclophosphamide—Cough—Donepezil—Alzheimer's disease	0.000273	0.00149	CcSEcCtD
Cyclophosphamide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000272	0.00149	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000271	0.00149	CcSEcCtD
Cyclophosphamide—Convulsion—Donepezil—Alzheimer's disease	0.000271	0.00148	CcSEcCtD
Cyclophosphamide—Hypertension—Donepezil—Alzheimer's disease	0.00027	0.00148	CcSEcCtD
Cyclophosphamide—Vision blurred—Memantine—Alzheimer's disease	0.000267	0.00146	CcSEcCtD
Cyclophosphamide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000267	0.00146	CcSEcCtD
Cyclophosphamide—Arthralgia—Donepezil—Alzheimer's disease	0.000266	0.00146	CcSEcCtD
Cyclophosphamide—Chest pain—Donepezil—Alzheimer's disease	0.000266	0.00146	CcSEcCtD
Cyclophosphamide—Myalgia—Donepezil—Alzheimer's disease	0.000266	0.00146	CcSEcCtD
Cyclophosphamide—Tremor—Memantine—Alzheimer's disease	0.000266	0.00146	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000263	0.00144	CcSEcCtD
Cyclophosphamide—Discomfort—Donepezil—Alzheimer's disease	0.000263	0.00144	CcSEcCtD
Cyclophosphamide—Anaemia—Memantine—Alzheimer's disease	0.000262	0.00144	CcSEcCtD
Cyclophosphamide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000262	0.00143	CcSEcCtD
Cyclophosphamide—Agitation—Memantine—Alzheimer's disease	0.000261	0.00143	CcSEcCtD
Cyclophosphamide—Body temperature increased—Galantamine—Alzheimer's disease	0.00026	0.00142	CcSEcCtD
Cyclophosphamide—Tremor—Rivastigmine—Alzheimer's disease	0.00026	0.00142	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000258	0.00141	CcSEcCtD
Cyclophosphamide—Confusional state—Donepezil—Alzheimer's disease	0.000257	0.00141	CcSEcCtD
Cyclophosphamide—Anaemia—Rivastigmine—Alzheimer's disease	0.000257	0.00141	CcSEcCtD
Cyclophosphamide—Malaise—Memantine—Alzheimer's disease	0.000256	0.0014	CcSEcCtD
Cyclophosphamide—Agitation—Rivastigmine—Alzheimer's disease	0.000255	0.0014	CcSEcCtD
Cyclophosphamide—Oedema—Donepezil—Alzheimer's disease	0.000255	0.0014	CcSEcCtD
Cyclophosphamide—Leukopenia—Memantine—Alzheimer's disease	0.000254	0.00139	CcSEcCtD
Cyclophosphamide—Infection—Donepezil—Alzheimer's disease	0.000253	0.00139	CcSEcCtD
Cyclophosphamide—Shock—Donepezil—Alzheimer's disease	0.000251	0.00137	CcSEcCtD
Cyclophosphamide—Palpitations—Memantine—Alzheimer's disease	0.000251	0.00137	CcSEcCtD
Cyclophosphamide—Malaise—Rivastigmine—Alzheimer's disease	0.00025	0.00137	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00025	0.00137	CcSEcCtD
Cyclophosphamide—Cough—Memantine—Alzheimer's disease	0.000248	0.00136	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000247	0.00135	CcSEcCtD
Cyclophosphamide—Convulsion—Memantine—Alzheimer's disease	0.000246	0.00135	CcSEcCtD
Cyclophosphamide—Palpitations—Rivastigmine—Alzheimer's disease	0.000245	0.00134	CcSEcCtD
Cyclophosphamide—Hypertension—Memantine—Alzheimer's disease	0.000245	0.00134	CcSEcCtD
Cyclophosphamide—Anorexia—Donepezil—Alzheimer's disease	0.000243	0.00133	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000242	0.00133	CcSEcCtD
Cyclophosphamide—Cough—Rivastigmine—Alzheimer's disease	0.000242	0.00133	CcSEcCtD
Cyclophosphamide—Chest pain—Memantine—Alzheimer's disease	0.000242	0.00132	CcSEcCtD
Cyclophosphamide—Arthralgia—Memantine—Alzheimer's disease	0.000242	0.00132	CcSEcCtD
Cyclophosphamide—Myalgia—Memantine—Alzheimer's disease	0.000242	0.00132	CcSEcCtD
Cyclophosphamide—Convulsion—Rivastigmine—Alzheimer's disease	0.000241	0.00132	CcSEcCtD
Cyclophosphamide—Hypertension—Rivastigmine—Alzheimer's disease	0.00024	0.00131	CcSEcCtD
Cyclophosphamide—Discomfort—Memantine—Alzheimer's disease	0.000239	0.00131	CcSEcCtD
Cyclophosphamide—Hypotension—Donepezil—Alzheimer's disease	0.000238	0.00131	CcSEcCtD
Cyclophosphamide—Myalgia—Rivastigmine—Alzheimer's disease	0.000236	0.00129	CcSEcCtD
Cyclophosphamide—Chest pain—Rivastigmine—Alzheimer's disease	0.000236	0.00129	CcSEcCtD
Cyclophosphamide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000236	0.00129	CcSEcCtD
Cyclophosphamide—Asthenia—Galantamine—Alzheimer's disease	0.000236	0.00129	CcSEcCtD
Cyclophosphamide—Confusional state—Memantine—Alzheimer's disease	0.000234	0.00128	CcSEcCtD
Cyclophosphamide—Discomfort—Rivastigmine—Alzheimer's disease	0.000233	0.00128	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000232	0.00127	CcSEcCtD
Cyclophosphamide—Oedema—Memantine—Alzheimer's disease	0.000232	0.00127	CcSEcCtD
Cyclophosphamide—Infection—Memantine—Alzheimer's disease	0.00023	0.00126	CcSEcCtD
Cyclophosphamide—Paraesthesia—Donepezil—Alzheimer's disease	0.000229	0.00125	CcSEcCtD
Cyclophosphamide—Confusional state—Rivastigmine—Alzheimer's disease	0.000228	0.00125	CcSEcCtD
Cyclophosphamide—Shock—Memantine—Alzheimer's disease	0.000228	0.00125	CcSEcCtD
Cyclophosphamide—Dyspnoea—Donepezil—Alzheimer's disease	0.000227	0.00125	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000227	0.00124	CcSEcCtD
Cyclophosphamide—Oedema—Rivastigmine—Alzheimer's disease	0.000227	0.00124	CcSEcCtD
Cyclophosphamide—Tachycardia—Memantine—Alzheimer's disease	0.000226	0.00124	CcSEcCtD
Cyclophosphamide—Diarrhoea—Galantamine—Alzheimer's disease	0.000225	0.00123	CcSEcCtD
Cyclophosphamide—Infection—Rivastigmine—Alzheimer's disease	0.000225	0.00123	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000224	0.00123	CcSEcCtD
Cyclophosphamide—Shock—Rivastigmine—Alzheimer's disease	0.000223	0.00122	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000222	0.00121	CcSEcCtD
Cyclophosphamide—Decreased appetite—Donepezil—Alzheimer's disease	0.000222	0.00121	CcSEcCtD
Cyclophosphamide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000221	0.00121	CcSEcCtD
Cyclophosphamide—Anorexia—Memantine—Alzheimer's disease	0.000221	0.00121	CcSEcCtD
Cyclophosphamide—Fatigue—Donepezil—Alzheimer's disease	0.00022	0.0012	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000219	0.0012	CcSEcCtD
Cyclophosphamide—Constipation—Donepezil—Alzheimer's disease	0.000218	0.00119	CcSEcCtD
Cyclophosphamide—Pain—Donepezil—Alzheimer's disease	0.000218	0.00119	CcSEcCtD
Cyclophosphamide—Dizziness—Galantamine—Alzheimer's disease	0.000218	0.00119	CcSEcCtD
Cyclophosphamide—Hypotension—Memantine—Alzheimer's disease	0.000216	0.00119	CcSEcCtD
Cyclophosphamide—Anorexia—Rivastigmine—Alzheimer's disease	0.000216	0.00118	CcSEcCtD
Cyclophosphamide—Hypotension—Rivastigmine—Alzheimer's disease	0.000212	0.00116	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000211	0.00116	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Donepezil—Alzheimer's disease	0.00021	0.00115	CcSEcCtD
Cyclophosphamide—Vomiting—Galantamine—Alzheimer's disease	0.000209	0.00115	CcSEcCtD
Cyclophosphamide—Paraesthesia—Memantine—Alzheimer's disease	0.000208	0.00114	CcSEcCtD
Cyclophosphamide—Rash—Galantamine—Alzheimer's disease	0.000208	0.00114	CcSEcCtD
Cyclophosphamide—Dermatitis—Galantamine—Alzheimer's disease	0.000207	0.00114	CcSEcCtD
Cyclophosphamide—Dyspnoea—Memantine—Alzheimer's disease	0.000206	0.00113	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000206	0.00113	CcSEcCtD
Cyclophosphamide—Headache—Galantamine—Alzheimer's disease	0.000206	0.00113	CcSEcCtD
Cyclophosphamide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000203	0.00111	CcSEcCtD
Cyclophosphamide—Urticaria—Donepezil—Alzheimer's disease	0.000203	0.00111	CcSEcCtD
Cyclophosphamide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000202	0.00111	CcSEcCtD
Cyclophosphamide—Body temperature increased—Donepezil—Alzheimer's disease	0.000202	0.0011	CcSEcCtD
Cyclophosphamide—Decreased appetite—Memantine—Alzheimer's disease	0.000201	0.0011	CcSEcCtD
Cyclophosphamide—Fatigue—Memantine—Alzheimer's disease	0.0002	0.00109	CcSEcCtD
Cyclophosphamide—Pain—Memantine—Alzheimer's disease	0.000198	0.00108	CcSEcCtD
Cyclophosphamide—Constipation—Memantine—Alzheimer's disease	0.000198	0.00108	CcSEcCtD
Cyclophosphamide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000197	0.00108	CcSEcCtD
Cyclophosphamide—Nausea—Galantamine—Alzheimer's disease	0.000195	0.00107	CcSEcCtD
Cyclophosphamide—Fatigue—Rivastigmine—Alzheimer's disease	0.000195	0.00107	CcSEcCtD
Cyclophosphamide—Pain—Rivastigmine—Alzheimer's disease	0.000194	0.00106	CcSEcCtD
Cyclophosphamide—Constipation—Rivastigmine—Alzheimer's disease	0.000194	0.00106	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Memantine—Alzheimer's disease	0.000191	0.00105	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000188	0.00103	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000187	0.00102	CcSEcCtD
Cyclophosphamide—Urticaria—Memantine—Alzheimer's disease	0.000184	0.00101	CcSEcCtD
Cyclophosphamide—Body temperature increased—Memantine—Alzheimer's disease	0.000183	0.001	CcSEcCtD
Cyclophosphamide—Asthenia—Donepezil—Alzheimer's disease	0.000183	0.001	CcSEcCtD
Cyclophosphamide—Pruritus—Donepezil—Alzheimer's disease	0.00018	0.000988	CcSEcCtD
Cyclophosphamide—Urticaria—Rivastigmine—Alzheimer's disease	0.00018	0.000986	CcSEcCtD
Cyclophosphamide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000179	0.000981	CcSEcCtD
Cyclophosphamide—Diarrhoea—Donepezil—Alzheimer's disease	0.000175	0.000956	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Memantine—Alzheimer's disease	0.000171	0.000934	CcSEcCtD
Cyclophosphamide—Dizziness—Donepezil—Alzheimer's disease	0.000169	0.000924	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000167	0.000914	CcSEcCtD
Cyclophosphamide—Asthenia—Memantine—Alzheimer's disease	0.000166	0.00091	CcSEcCtD
Cyclophosphamide—Pruritus—Memantine—Alzheimer's disease	0.000164	0.000897	CcSEcCtD
Cyclophosphamide—Asthenia—Rivastigmine—Alzheimer's disease	0.000163	0.00089	CcSEcCtD
Cyclophosphamide—Vomiting—Donepezil—Alzheimer's disease	0.000162	0.000888	CcSEcCtD
Cyclophosphamide—Rash—Donepezil—Alzheimer's disease	0.000161	0.000881	CcSEcCtD
Cyclophosphamide—Dermatitis—Donepezil—Alzheimer's disease	0.000161	0.00088	CcSEcCtD
Cyclophosphamide—Pruritus—Rivastigmine—Alzheimer's disease	0.00016	0.000878	CcSEcCtD
Cyclophosphamide—Headache—Donepezil—Alzheimer's disease	0.00016	0.000875	CcSEcCtD
Cyclophosphamide—Diarrhoea—Memantine—Alzheimer's disease	0.000158	0.000868	CcSEcCtD
Cyclophosphamide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000155	0.000849	CcSEcCtD
Cyclophosphamide—Dizziness—Memantine—Alzheimer's disease	0.000153	0.000839	CcSEcCtD
Cyclophosphamide—Nausea—Donepezil—Alzheimer's disease	0.000151	0.00083	CcSEcCtD
Cyclophosphamide—Dizziness—Rivastigmine—Alzheimer's disease	0.00015	0.00082	CcSEcCtD
Cyclophosphamide—Vomiting—Memantine—Alzheimer's disease	0.000147	0.000806	CcSEcCtD
Cyclophosphamide—Rash—Memantine—Alzheimer's disease	0.000146	0.0008	CcSEcCtD
Cyclophosphamide—Dermatitis—Memantine—Alzheimer's disease	0.000146	0.000799	CcSEcCtD
Cyclophosphamide—Headache—Memantine—Alzheimer's disease	0.000145	0.000794	CcSEcCtD
Cyclophosphamide—Vomiting—Rivastigmine—Alzheimer's disease	0.000144	0.000789	CcSEcCtD
Cyclophosphamide—Rash—Rivastigmine—Alzheimer's disease	0.000143	0.000782	CcSEcCtD
Cyclophosphamide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000143	0.000782	CcSEcCtD
Cyclophosphamide—Headache—Rivastigmine—Alzheimer's disease	0.000142	0.000777	CcSEcCtD
Cyclophosphamide—Nausea—Memantine—Alzheimer's disease	0.000138	0.000753	CcSEcCtD
Cyclophosphamide—Nausea—Rivastigmine—Alzheimer's disease	0.000135	0.000737	CcSEcCtD
Cyclophosphamide—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.2e-05	0.000244	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.2e-05	0.000244	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.19e-05	0.000241	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	1.19e-05	0.000241	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.19e-05	0.00024	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CALM1—Alzheimer's disease	1.18e-05	0.000239	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.18e-05	0.000239	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—APOE—Alzheimer's disease	1.17e-05	0.000238	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.17e-05	0.000237	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.17e-05	0.000237	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CAV1—Alzheimer's disease	1.16e-05	0.000236	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.15e-05	0.000234	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.13e-05	0.00023	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.12e-05	0.000228	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	1.12e-05	0.000227	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.11e-05	0.000225	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ACHE—Alzheimer's disease	1.1e-05	0.000223	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.1e-05	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	1.09e-05	0.000221	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.09e-05	0.00022	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.09e-05	0.00022	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.08e-05	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.08e-05	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.07e-05	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.07e-05	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.07e-05	0.000217	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.07e-05	0.000216	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.06e-05	0.000216	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.06e-05	0.000215	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.05e-05	0.000212	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.05e-05	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.04e-05	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	1.03e-05	0.000209	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ENO1—Alzheimer's disease	1.03e-05	0.000209	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.03e-05	0.000209	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	1.02e-05	0.000207	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PPARG—Alzheimer's disease	1.02e-05	0.000207	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	1.02e-05	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	1.01e-05	0.000205	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.01e-05	0.000205	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.01e-05	0.000205	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MAOB—Alzheimer's disease	1e-05	0.000204	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—INS—Alzheimer's disease	1e-05	0.000203	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1e-05	0.000203	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	9.9e-06	0.000201	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	9.89e-06	0.000201	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	9.87e-06	0.0002	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	9.87e-06	0.0002	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.79e-06	0.000199	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	9.79e-06	0.000198	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	9.79e-06	0.000198	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.7e-06	0.000197	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GAPDH—Alzheimer's disease	9.67e-06	0.000196	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—BCHE—Alzheimer's disease	9.59e-06	0.000195	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—A2M—Alzheimer's disease	9.57e-06	0.000194	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.56e-06	0.000194	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.46e-06	0.000192	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	9.38e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—BCHE—Alzheimer's disease	9.38e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	9.37e-06	0.00019	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—A2M—Alzheimer's disease	9.34e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	9.34e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	9.33e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ACHE—Alzheimer's disease	9.32e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—LPL—Alzheimer's disease	9.31e-06	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	9.22e-06	0.000187	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.11e-06	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	9.05e-06	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	9.03e-06	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.93e-06	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	8.85e-06	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.85e-06	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—A2M—Alzheimer's disease	8.8e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NOS3—Alzheimer's disease	8.79e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	8.77e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	8.74e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ENO1—Alzheimer's disease	8.74e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—A2M—Alzheimer's disease	8.72e-06	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	8.58e-06	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	8.57e-06	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—LPL—Alzheimer's disease	8.53e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.53e-06	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	8.38e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	8.32e-06	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	8.23e-06	0.000167	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ACHE—Alzheimer's disease	8.12e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—BCHE—Alzheimer's disease	8.12e-06	0.000165	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—Alzheimer's disease	8.04e-06	0.000163	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—INPP5D—Alzheimer's disease	8.03e-06	0.000163	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	7.88e-06	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CALM1—Alzheimer's disease	7.83e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOE—Alzheimer's disease	7.8e-06	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	7.8e-06	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	7.8e-06	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.78e-06	0.000158	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAV1—Alzheimer's disease	7.73e-06	0.000157	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	7.68e-06	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	7.66e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	7.65e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	7.65e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ENO1—Alzheimer's disease	7.61e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS1—Alzheimer's disease	7.61e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	7.59e-06	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.57e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	7.56e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	7.53e-06	0.000153	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.52e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	7.5e-06	0.000152	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	7.46e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	7.43e-06	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	7.39e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	7.36e-06	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.25e-06	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CALM1—Alzheimer's disease	7.18e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.17e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.17e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOE—Alzheimer's disease	7.15e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.11e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.11e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAV1—Alzheimer's disease	7.09e-06	0.000144	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—BCHE—Alzheimer's disease	7.08e-06	0.000143	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	6.97e-06	0.000141	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—LPL—Alzheimer's disease	6.89e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	6.84e-06	0.000139	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—Alzheimer's disease	6.8e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—LPL—Alzheimer's disease	6.73e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.71e-06	0.000136	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PLCB1—Alzheimer's disease	6.68e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	6.67e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—INS—Alzheimer's disease	6.67e-06	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.63e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	6.61e-06	0.000134	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ABCA1—Alzheimer's disease	6.47e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.45e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.45e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	6.4e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	6.37e-06	0.000129	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.29e-06	0.000128	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.24e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—Alzheimer's disease	6.23e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	6.2e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.19e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.12e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—INS—Alzheimer's disease	6.11e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.1e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	6.06e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.05e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.96e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—Alzheimer's disease	5.85e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—LPL—Alzheimer's disease	5.83e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CALM1—Alzheimer's disease	5.79e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—Alzheimer's disease	5.77e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.75e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAV1—Alzheimer's disease	5.72e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	5.71e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.69e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CALM1—Alzheimer's disease	5.66e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—Alzheimer's disease	5.64e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAV1—Alzheimer's disease	5.59e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.58e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.55e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—Alzheimer's disease	5.36e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	5.35e-06	0.000108	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.26e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	5.25e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.23e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.21e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.2e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.19e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—LPL—Alzheimer's disease	5.08e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—Alzheimer's disease	5.03e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.95e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—INS—Alzheimer's disease	4.93e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—Alzheimer's disease	4.91e-06	9.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CALM1—Alzheimer's disease	4.9e-06	9.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	4.9e-06	9.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—Alzheimer's disease	4.89e-06	9.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAV1—Alzheimer's disease	4.84e-06	9.82e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—INS—Alzheimer's disease	4.82e-06	9.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.79e-06	9.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—LPL—Alzheimer's disease	4.74e-06	9.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.69e-06	9.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.69e-06	9.51e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.68e-06	9.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.6e-06	9.32e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.57e-06	9.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.38e-06	8.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.36e-06	8.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.36e-06	8.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—Alzheimer's disease	4.32e-06	8.77e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.32e-06	8.76e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.31e-06	8.74e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.27e-06	8.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.27e-06	8.66e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—Alzheimer's disease	4.26e-06	8.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—Alzheimer's disease	4.26e-06	8.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—Alzheimer's disease	4.23e-06	8.57e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.22e-06	8.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—INS—Alzheimer's disease	4.17e-06	8.46e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.11e-06	8.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—Alzheimer's disease	4.04e-06	8.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.03e-06	8.16e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.01e-06	8.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	3.99e-06	8.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.99e-06	8.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—Alzheimer's disease	3.98e-06	8.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.97e-06	8.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	3.95e-06	8.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	3.94e-06	7.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	3.87e-06	7.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	3.8e-06	7.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—INS—Alzheimer's disease	3.73e-06	7.55e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.71e-06	7.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.66e-06	7.42e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—INS—Alzheimer's disease	3.64e-06	7.37e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.49e-06	7.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.46e-06	7.02e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.44e-06	6.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—INS—Alzheimer's disease	3.43e-06	6.95e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.42e-06	6.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—INS—Alzheimer's disease	3.4e-06	6.89e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.35e-06	6.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.27e-06	6.62e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.19e-06	6.47e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.13e-06	6.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.01e-06	6.09e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.99e-06	6.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.98e-06	6.04e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.92e-06	5.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.82e-06	5.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.75e-06	5.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.72e-06	5.52e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—Alzheimer's disease	2.69e-06	5.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.63e-06	5.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.62e-06	5.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.6e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.46e-06	4.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.28e-06	4.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—INS—Alzheimer's disease	2.24e-06	4.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.99e-06	4.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.96e-06	3.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.94e-06	3.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.8e-06	3.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.68e-06	3.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.5e-06	3.05e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.47e-06	2.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.38e-06	2.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.37e-06	2.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.03e-07	1.83e-05	CbGpPWpGaD
